Iqvia reports fourth-quarter and full-year 2023 results; issues full-year 2024 guidance

Research triangle park, n.c.--(business wire)--iqvia holdings inc. (“iqvia”) (nyse:iqv), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended december 31, 2023. fourth-quarter 2023 operating results revenue for the fourth quarter of $3,868 million increased 3.5 percent on a reported basis and 2.6 percent at constant currency, compared to the fourth quarter of 20.
IQV Ratings Summary
IQV Quant Ranking